Research & Development Department, Nipro Patch Co., Ltd., Saitama, Japan.
Eur J Pharm Biopharm. 2011 Aug;78(3):415-21. doi: 10.1016/j.ejpb.2011.03.005. Epub 2011 Mar 21.
The study was performed to evaluate the percutaneous penetration of ketoprofen after transdermal administration using a microdialysis technique in pigs, in comparison with rats. Ketoprofen release from patches was determined by analysis of the remaining drug content after application to hairless rats and pigs. Skin and knee joint penetration of ketoprofen was tested by microdialysis, and recovery was determined by retrodialysis. Residual rates in hairless rats and pigs were 68.1 ± 1.6% and 81.7 ± 4.4%, respectively, at 10h. The average recoveries of ketoprofen over 480 min in the skin and knee joint cases were 72.0 ± 3.4% and 9.8 ± 6.2% in rats and 72.3 ± 2.5% and 57.6 ± 3.1% in pigs, respectively. In rats, ketoprofen was rapidly absorbed with transdermal administration, with C(max) values of 191.7 ± 76.2 and 35.5 ± 21.7 ng/mL and AUC(0-8h) values of 918.2 ± 577.5 and 195.9 ± 137.1 ngh/mL, respectively, for the skin and knee joint. The C(max) values for the pig were 20.9 ± 18.5 and 3.7 ± 3.0 ng/mL, with AUC(0-8h) values of 73.1 ± 69.2 and 16.1 ± 16.1 ngh/mL. Ketoprofen concentrations within skin and knee joint of non-application sites in rats and pigs were less than 0.8 ng/mL. Transdermal administration of ketoprofen significantly reduced prostaglandin E2 levels in the skin of the application site and showed a tendency for inhibition in the knee joint. We thus demonstrated that topical patches containing ketoprofen can deliver the drug through the skin and knee joint of pigs and rats via direct diffusion, and microdialysis data with the pig may be useful for the prediction of human tissue penetration of drugs with transdermal administration.
本研究采用微透析技术,比较了猪和大鼠经皮给药后酮洛芬的透皮渗透情况。通过分析应用于无毛大鼠和猪后的剩余药物含量,确定了贴剂中酮洛芬的释放情况。通过微透析测试了酮洛芬在皮肤和膝关节中的渗透,通过逆行透析确定了回收率。在 10 小时时,无毛大鼠和猪的残留率分别为 68.1 ± 1.6%和 81.7 ± 4.4%。在皮肤和膝关节情况下,480 分钟内酮洛芬的平均回收率分别为大鼠的 72.0 ± 3.4%和 9.8 ± 6.2%,以及猪的 72.3 ± 2.5%和 57.6 ± 3.1%。在大鼠中,酮洛芬经皮给药后迅速吸收,皮肤和膝关节的 C(max)值分别为 191.7 ± 76.2 和 35.5 ± 21.7 ng/mL,AUC(0-8h)值分别为 918.2 ± 577.5 和 195.9 ± 137.1 ngh/mL。猪的 C(max)值分别为 20.9 ± 18.5 和 3.7 ± 3.0 ng/mL,AUC(0-8h)值分别为 73.1 ± 69.2 和 16.1 ± 16.1 ngh/mL。大鼠和猪非应用部位皮肤和膝关节中的酮洛芬浓度均小于 0.8 ng/mL。酮洛芬经皮给药可显著降低应用部位皮肤中前列腺素 E2 的水平,并表现出对膝关节的抑制趋势。因此,我们证明了含有酮洛芬的局部贴剂可以通过猪和大鼠的皮肤和膝关节直接扩散递药,并且使用猪的微透析数据可能有助于预测经皮给药药物在人体组织中的渗透。